Home6855 • HKG
add
Ascentage Pharma Group International
Previous close
$26.95
Year range
$15.42 - $29.80
Market cap
8.48B HKD
Avg Volume
1.86M
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
Market news
Financials
Income Statement
Revenue
Net income
(CNY) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 39.64M | -30.42% |
Operating expense | 299.48M | 3.98% |
Net income | -261.64M | -9.89% |
Net profit margin | -660.02 | -57.94% |
Earnings per share | — | — |
EBITDA | -246.34M | -8.30% |
Effective tax rate | 1.86% | — |
Balance Sheet
Total assets
Total liabilities
(CNY) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.10B | -26.84% |
Total assets | 2.50B | -11.66% |
Total liabilities | 2.43B | 0.34% |
Total equity | 70.63M | — |
Shares outstanding | 290.05M | — |
Price to book | 128.33 | — |
Return on assets | -26.60% | — |
Return on capital | -35.64% | — |
Cash Flow
Net change in cash
(CNY) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -261.64M | -9.89% |
Cash from operations | -178.81M | -12.20% |
Cash from investing | 43.35M | 135.82% |
Cash from financing | -43.44M | -150.66% |
Net change in cash | -175.97M | -2.00% |
Free cash flow | -160.41M | 11.89% |
About
CEO
Founded
2009
Website
Employees
583